Sosei Group renamed Nxera Pharma

The pharma company known as Sosei Group (TYO 4565) or Sosei Heptares will now go by the name Nxera Pharma.

Subsidiaries of the Japanese group—Heptares Therapeutics and Idorsia Pharmaceuticals Japan and Korea—will all go under the Nxera brand.

"Determination to lead the next era of medicine"Chris Cargill, president and chief executive of Nxera, said: “Our name change from Sosei Group to Nxera Pharma marks a pivotal moment in our company’s journey. It follows the significant growth and development of the business, which has been accelerated through several key strategic acquisitions in recent years, including Heptares Therapeutics in 2015 and the Idorsia Pharmaceuticals Japan and Korea businesses in 2023.